Clinical trial
A Double-blind Randomised Controlled Clinical Trial of Lofexidine Versus Diazepam in the Management of the Opioid Withdrawal Syndrome During Inpatient Detoxification in Singapore
NCT01675648 is registered in ClinicalTrials.gov with Institute of Mental Health, Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind Randomised Controlled Clinical Trial of Lofexidine Versus Diazepam in the Management of the Opioid Withdrawal Syndrome During Inpatient Detoxification in Singapore
- Lead sponsor
- Institute of Mental Health, Singapore
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- July 31, 2015
- Enrollment
- 112 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
opiate dependent patients who are undergoing inpatient detoxification in singapore